Many breast cancer survivors may be able to forgo mammograms in old age

by Denise MannOlder breast cancer survivors often have other medical issues and a shorter life expectancy than younger breast cancer survivors. What's more, their cancers are often slow-growing, a

Updated on: January 15,2024

Many breast cancer survivors may be able to forgo mammograms in old age

by Denise MannOlder breast cancer survivors often have other medical issues and a shorter life expectancy than younger breast cancer survivors. What's more, their cancers are often slow-growing, a

Updated on:January 15,2024

Novel pretargeted radionuclide therapy for HER2-expressing cancers shows promise

by Society of Nuclear Medicine and Molecular ImagingTransversal (A), coronal (B), sagittal (C) nanoSPECT/CT images and maximum intensity projection (D) obtained 30 h after injection of pretargeted&nbs

Updated on: March 06,2024

Novel pretargeted radionuclide therapy for HER2-expressing cancers shows promise

by Society of Nuclear Medicine and Molecular ImagingTransversal (A), coronal (B), sagittal (C) nanoSPECT/CT images and maximum intensity projection (D) obtained 30 h after injection of pretargeted&nbs

Updated on:March 06,2024

Molecular change to immunotherapy antibody could accelerate immune response to cancer

byWeizmann Institute of ScienceTissue sample of a particularly aggressive skin cancer reveals immune cells (yellow) that express on their surfaces a “brake pedal” receptor called FcgIIb (purple)

Updated on: January 02,2024

Molecular change to immunotherapy antibody could accelerate immune response to cancer

byWeizmann Institute of ScienceTissue sample of a particularly aggressive skin cancer reveals immune cells (yellow) that express on their surfaces a “brake pedal” receptor called FcgIIb (purple)

Updated on:January 02,2024

Clinical trial generates promising results for immunotherapy drug nivolumab in patients with advanced skin cancer

byWileyCredit: CC0 Public DomainNumerous studies have shown that drugs called immune checkpoint inhibitors can boost the immune system's response against various cancers. Now a phase II clin

Updated on: January 02,2024

Clinical trial generates promising results for immunotherapy drug nivolumab in patients with advanced skin cancer

byWileyCredit: CC0 Public DomainNumerous studies have shown that drugs called immune checkpoint inhibitors can boost the immune system's response against various cancers. Now a phase II clin

Updated on:January 02,2024

Immune response against skin-dwelling viruses prevents cancer

by Massachusetts General HospitalEarly skin cancer that is colonized with a commensal papillomavirus looks like a wart to the immune system and is effectively eliminated. Keratin 6+ hyperplastic

Updated on: April 14,2024

Immune response against skin-dwelling viruses prevents cancer

by Massachusetts General HospitalEarly skin cancer that is colonized with a commensal papillomavirus looks like a wart to the immune system and is effectively eliminated. Keratin 6+ hyperplastic

Updated on:April 14,2024

Investigators reveal changes to immune status in patient tumors after radiation

by Roswell Park Comprehensive Cancer CenterCredit: Pixabay/CC0 Public DomainLittle is known about how radiation therapy to kill cancer cells affects immune cells and other components of patient tumors

Updated on: January 30,2024

Investigators reveal changes to immune status in patient tumors after radiation

by Roswell Park Comprehensive Cancer CenterCredit: Pixabay/CC0 Public DomainLittle is known about how radiation therapy to kill cancer cells affects immune cells and other components of patient tumors

Updated on:January 30,2024

Study shows checkpoint inhibitor prolongs survival in patients with certain head and neck cancers

by Anne Doerr,Yale UniversityCredit: stock.adobe.comThe checkpoint inhibitor pembrolizumab (Keytruda) increases the survival time of patients with advanced head and neck cancers, according to a

Updated on: May 31,2024

Study shows checkpoint inhibitor prolongs survival in patients with certain head and neck cancers

by Anne Doerr,Yale UniversityCredit: stock.adobe.comThe checkpoint inhibitor pembrolizumab (Keytruda) increases the survival time of patients with advanced head and neck cancers, according to a

Updated on:May 31,2024

New research casts doubt on role of fungus in driving pancreatic cancer

byDuke University Medical CenterAxial CT image with i.v. contrast. Macrocystic adenocarcinoma of the pancreatic head. Credit: public domainFour years ago, a report that a common species of fungu

Updated on: January 12,2024

New research casts doubt on role of fungus in driving pancreatic cancer

byDuke University Medical CenterAxial CT image with i.v. contrast. Macrocystic adenocarcinoma of the pancreatic head. Credit: public domainFour years ago, a report that a common species of fungu

Updated on:January 12,2024

Research reveals promising new combination treatment for bladder cancer patients

by Memorial Sloan Kettering Cancer CenterCredit: OpenStax College, CC BY 3.0, via Wikimedia CommonsResearchers from Memorial Sloan Kettering Cancer Center (MSK) shared a promising treatment

Updated on: February 03,2024

Research reveals promising new combination treatment for bladder cancer patients

by Memorial Sloan Kettering Cancer CenterCredit: OpenStax College, CC BY 3.0, via Wikimedia CommonsResearchers from Memorial Sloan Kettering Cancer Center (MSK) shared a promising treatment

Updated on:February 03,2024

Researchers identify immune cell that helps kill bladder cancer tumors

by The Mount Sinai HospitalMyeloid immune cells alongsidered blood cells in an electron micrograph of human blood. Credit: National Cancer InstituteMount Sinai researchers have made two imp

Updated on: February 18,2024

Researchers identify immune cell that helps kill bladder cancer tumors

by The Mount Sinai HospitalMyeloid immune cells alongsidered blood cells in an electron micrograph of human blood. Credit: National Cancer InstituteMount Sinai researchers have made two imp

Updated on:February 18,2024

New molecular blocker halts breast cancer metastasis, says study

byBar-Ilan UniversityA cell-permeable peptide derived from the second proline-rich region of Pyk2 blocks spontaneous lung metastasis in an immune-competent xenograft mouse model. Credit:On

Updated on: January 16,2024

New molecular blocker halts breast cancer metastasis, says study

byBar-Ilan UniversityA cell-permeable peptide derived from the second proline-rich region of Pyk2 blocks spontaneous lung metastasis in an immune-competent xenograft mouse model. Credit:On

Updated on:January 16,2024

Lung cancer screening more cost effective when using risk model-based strategies, study shows

byUniversity of Texas M. D. Anderson Cancer CenterCredit: Pixabay/CC0 Public DomainRisk model-based lung cancer screening strategies, which select individuals based on personal risk, are more co

Updated on: January 16,2024

Lung cancer screening more cost effective when using risk model-based strategies, study shows

byUniversity of Texas M. D. Anderson Cancer CenterCredit: Pixabay/CC0 Public DomainRisk model-based lung cancer screening strategies, which select individuals based on personal risk, are more co

Updated on:January 16,2024